Our data therefore demonstrate physiological roles for APP in membrane-dependent protein aggregation, involving molecular mechanisms, which when disrupted by Aβ peptides, trigger Alzheimer’s disease-relevant pathologies. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.